Microarray analysis
Microarray analysis is a powerful technique utilized by geneticists to compare and analyze DNA fragments side by side. This method involves placing hundreds to millions of DNA oligonucleotides, known as probes, on a small substrate, such as a glass slide, enabling simultaneous testing of specific genes. The probes can be tagged with fluorescent substances for easy identification against a background of other genetic material. Initially developed for pharmaceutical research, microarray analysis allows for the examination of genetic structures and protein expressions in patient groups, facilitating targeted drug therapies, such as Herceptin for breast cancer. Additionally, it is employed in academia to study disease processes by characterizing normal genetic structures and identifying mutations linked to specific symptoms. Despite its advantages, challenges such as standardization, normalization of data, and the complexity of study design remain. Nonetheless, microarray analysis has significantly advanced research in genetics and pharmaceuticals, enabling faster testing and deeper insights into genetic diseases and treatment outcomes.
Microarray analysis
SIGNIFICANCE: Microarray analysis is the procedure used by geneticists to place similar DNA fragments side by side for comparison. With this process, they can compare genetic structure and reactions of genetic material.
Procedure
For analysis, several hundred to millions of DNA oligonucleotides are placed on a small piece of glass, a filter, or a silicon slide. These oligonucleotides, called probes, are bonded to the substrate by a chemical. Usually the DNA is focused on several specific genes, which are lined up by number, or type. This task is performed by a robot due to its precise requirements and microscopic size. Testing on the genes can be performed simultaneously. The genes of interest are often tagged with a fluorescent substance, so that they stand out from the others and can be easily compared.
![Observing microarray sample. Dr. Louis Staudt of the Metabolism Branch at the National Cancer Institute (NCI) observes a microarray sample at the preparation station and scanner. By Bill Branson (Photographer) [Public domain or Public domain], via Wikimedia Commons 94416584-89396.jpg](https://imageserver.ebscohost.com/img/embimages/ers/sp/embedded/94416584-89396.jpg?ephost1=dGJyMNHX8kSepq84xNvgOLCmsE2epq5Srqa4SK6WxWXS)
![DNA microarray. it's a DNA microarray.DNA - Deoxyribonucleic acid. By Duncharris at en.wikipedia ([1] Transferred from en.wikipedia) [Public domain], from Wikimedia Commons 94416584-89397.jpg](https://imageserver.ebscohost.com/img/embimages/ers/sp/embedded/94416584-89397.jpg?ephost1=dGJyMNHX8kSepq84xNvgOLCmsE2epq5Srqa4SK6WxWXS)
The probes can be further processed into spotted microarrays. For this type of microarray, smaller fragments of the DNA are dropped onto another glass slide. This task is performed by using needles to withdraw the DNA fragments. Both the spotted microarrays and the microarrays are then scanned using either laser or radiographic imaging.
Uses for Microarray Analysis
The scan produces a database of genetic information that can be further analyzed and tested. Microarray analysis was initially intended for pharmaceutical research. By examining the genes from a group of patients with the same condition, drug researchers can view the genetic structure and the proteins produced by these genes. With this information, researchers can use this information to target drug therapy. An example of this is the development of Herceptin for breast cancer patients who are HERS positive.
Researchers in academia now use DNA microarray analysis data to better understand disease processes. Using this data, researchers are able to describe a profile of normal genetic structure, as well as, specific genetic mutations leading to disease. This process defines the specific genetic changes (genotype) related to specific symptoms (phenotype). Some research is performed by exposing the genetic material to pathogenic organisms or to drugs, and then examining the response of the genes.
Forensic science uses genetic material from a suspected perpetrator, and compares it with DNA left on the victim. Microarrays of genetic material can be used to define specific microorganisms, such as various influenza viruses. They can be used for diagnosis of conditions caused by genetic mutations. In some conditions, the same symptoms can be caused by a variety of genetic mutations, usually within one gene.
Issues with Microarray Research
Despite the advantages of DNA microarray analysis, there are still issues that must be overcome. The first one is standardization of the microarrays. At the present time, there are a number of variables in the process of developing microarrays of DNA materials. These variables include the type of surface used, the process of fabricating the microarray and the actual analysis of the derived data. Efforts are being made to standardize microarrays. A checklist called the Minimum Information About a Microarray Experiment (MIAME) was developed, but this checklist is not complete. Currently, the US Food and Drug Administration (FDA) is developing standards and quality control for DNA microarray data.
Another issue is the normalization of DNA microarrays. Normalization facilitates the statistical analysis of the data, by organizing them into a database. This process of normalization is more complicated with microarray data due to its large numbers of records and multiple dimensions for each piece of genetic data. Some of these bits of data are irrelevant and can produce a false positive or false negative response. Statistical packages that normalize microarray data are now available.
Study design for microarray analysis must allow for of the genetic material within the microarray. Replication is required to draw valid conclusions from these studies. It provides multiple records for a single bit of genetic material. It is important that sample preparation be communicated so that summary statistics will be accurate.
Impact
Microarray analysis has revolutionized pharmaceutical and genetic research. It has given pharmaceutical researchers the ability to develop drugs that are specific to demographic groups. The ability to actually compare and contrast genes is providing new information about the source of medical conditions. Since it tests a group of genes, microarray analysis permits researchers to test large volumes of genetic material much more quickly. From this information, it is possible to test an individual for a genetic disease, verify the diagnosis, and even to predict the likely outcome of treatment.
Key terms
- nucleotidesthe two lengthy strands made of sugar and phosphate groups that form the outside structure of the DNA molecule
- oligonucleotidea fragment of a DNA sample used for microarray analysis
- probea sample of DNA which is part of a microarray
Bibliography
Asmare, Zelalem and Mulat Erkihun. "Recent Application of DNA Microarray Techniques to Diagnose Infectious Disease." Dove Medical Press, vol. 2023, no. 15, 10 Nov. 2023, doi.org/10.2147/PLMI.S424275. Accessed 5 Sept. 2024.
Causton, Helen, John Quackenbush, and Alvis Brazma. Microarray Gene Expression Data Analysis: A Beginner’s Guide. Hoboken: Wiley-Blackwell, 2003. Print.
Cleator, Susan J., et al. “The Effect of the Stromal Component of Breast Tumours on Prediction of Clinical Outcome Using Gene Expression Microarray Analysis.” Breast Cancer Research August 2006. Print.
Elkins, Kelly M. Forensic DNA Biology: A Laboratory Manual. Waltham: Academic Press, 2013. Print.
Emmert-Streib, Frank, and Mathias Dehmer. Analysis of Microarray Data: A Network-Based Approach. Berlin: Wiley, 2008. Print.
Singleton, Paul. Dictionary of DNA and Genome Technology. 3d ed. Hoboken: Wiley, 2013. Print.
Tan, Aik Choon, Tianhai Tian, and Junbai Wang. Next Generation Microarray Bioinformatics: Methods and Protocols. New York: Humana, 2012. Print.